ESTRO 2025 - Abstract Book

S2884

Physics - Dose prediction, optimisation and applications of photon and electron planning

ESTRO 2025

Conclusion: IMPT for vulvar cancer has the potential to reduce doses to OARs while maintaining target coverage. Despite changes in the vulvar region during the course of radiation treatment, IMPT appears to be adequately robust for delivery.

Keywords: Proton Beam Therapy, Vulvar cancer, Robustness

References: 1. Verma, V., Simone, C. B., Wahl, A. O., Beriwal, S., & Mehta, M. P. (2016). Proton radiotherapy for gynecologic neoplasms. Acta Oncologica , 55 (11), 1257–1265. https://doi.org/10.1080/0284186x.2016.1205218